2026 Global: Blood Glucose Monitoring System (Bgms) Market -Competitive Review (2032) report
Description
The 2026 Global: Blood Glucose Monitoring System (Bgms) Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Roche Diagnostics, Basel, Switzerland, commands a leading share of the global BGMS market through its Accu-Chek line, a long-standing portfolio of traditional meters and related testing systems that emphasize accuracy and reliability. Abbott Laboratories, Abbott Park, Illinois, United States, complements the field with the FreeStyle meter family and its growing connected devices, reinforcing a broad ecosystem of glucose monitoring and management. Dexcom, Inc., San Diego, California, United States, anchors continuous glucose monitoring, delivering dexterous sensors and software that enable real-time glucose insight and remote management for varying treatment pathways. Ascensia Diabetes Care, Basel, Switzerland, drives adoption of Contour meters and adjacent testing solutions, focusing on ease of use and data connectivity across platforms. Medtronic plc, Dublin, Ireland, advances BGMS compatibility within its broader diabetes care portfolio, emphasizing integrated devices, pumps, and CGM technologies that support automated insulin delivery and digital health interfaces. Together, they shape a diverse, patient-centric market globally.
Arkray, Inc., Kyoto, Japan, is a major Asia-Pacific supplier of glucose meters and strips, known for cost-efficient models such as the Glucocard series and a broad regional footprint. Nipro Corporation, Osaka, Japan, extends its glucose monitoring business through Nipro Diagnostics and a portfolio that includes compact meters and compatible test strips, targeting clinics and families alike. LifeScan, Inc., New Brunswick, New Jersey, United States, maintains a long-standing presence with OneTouch meters that emphasize usability and reliability, supporting both home users and healthcare providers. A&D Company, Limited, Tokyo, Japan, offers a compact line of glucose meters and associated accessories marketed to domestic and international customers, with a focus on accuracy, durability, and data handling. Menarini Diagnostics, Florence, Italy, presents Glucocard- and related device lines as part of a diversified diagnostic portfolio, leveraging the headquarters base in Italy and an expanding global network to reach emerging markets. In doing so, they diversify.
Together, the ten companies outlined here shape a BGMS landscape that blends traditional meter platforms with next-generation continuous glucose monitoring, sharing emphasis on accuracy, user experience, and data connectivity. Market dynamics show intensified competition among global device players, accelerated by digital health integration, cloud-based data management, and interoperability with insulin pumps and mobile ecosystems. Regions such as North America and Europe, along with expanding Asian markets, drive adoption, while payer policies and reimbursement frameworks influence device choice and testing frequency. Consumers benefit from broader product portfolios, more accessible pricing, and stronger customer support, though fragmentation in meter formats and strip standards remains a challenge. For researchers and clinicians, this competitive environment offers opportunities to study device performance across brands and to assess patient outcomes linked to metering accuracy and CGM technologies. Ongoing consolidation, partnerships, and regulatory alignment will continue shaping BGMS access and innovation in the coming decade and beyond.
Roche Diagnostics, Basel, Switzerland, commands a leading share of the global BGMS market through its Accu-Chek line, a long-standing portfolio of traditional meters and related testing systems that emphasize accuracy and reliability. Abbott Laboratories, Abbott Park, Illinois, United States, complements the field with the FreeStyle meter family and its growing connected devices, reinforcing a broad ecosystem of glucose monitoring and management. Dexcom, Inc., San Diego, California, United States, anchors continuous glucose monitoring, delivering dexterous sensors and software that enable real-time glucose insight and remote management for varying treatment pathways. Ascensia Diabetes Care, Basel, Switzerland, drives adoption of Contour meters and adjacent testing solutions, focusing on ease of use and data connectivity across platforms. Medtronic plc, Dublin, Ireland, advances BGMS compatibility within its broader diabetes care portfolio, emphasizing integrated devices, pumps, and CGM technologies that support automated insulin delivery and digital health interfaces. Together, they shape a diverse, patient-centric market globally.
Arkray, Inc., Kyoto, Japan, is a major Asia-Pacific supplier of glucose meters and strips, known for cost-efficient models such as the Glucocard series and a broad regional footprint. Nipro Corporation, Osaka, Japan, extends its glucose monitoring business through Nipro Diagnostics and a portfolio that includes compact meters and compatible test strips, targeting clinics and families alike. LifeScan, Inc., New Brunswick, New Jersey, United States, maintains a long-standing presence with OneTouch meters that emphasize usability and reliability, supporting both home users and healthcare providers. A&D Company, Limited, Tokyo, Japan, offers a compact line of glucose meters and associated accessories marketed to domestic and international customers, with a focus on accuracy, durability, and data handling. Menarini Diagnostics, Florence, Italy, presents Glucocard- and related device lines as part of a diversified diagnostic portfolio, leveraging the headquarters base in Italy and an expanding global network to reach emerging markets. In doing so, they diversify.
Together, the ten companies outlined here shape a BGMS landscape that blends traditional meter platforms with next-generation continuous glucose monitoring, sharing emphasis on accuracy, user experience, and data connectivity. Market dynamics show intensified competition among global device players, accelerated by digital health integration, cloud-based data management, and interoperability with insulin pumps and mobile ecosystems. Regions such as North America and Europe, along with expanding Asian markets, drive adoption, while payer policies and reimbursement frameworks influence device choice and testing frequency. Consumers benefit from broader product portfolios, more accessible pricing, and stronger customer support, though fragmentation in meter formats and strip standards remains a challenge. For researchers and clinicians, this competitive environment offers opportunities to study device performance across brands and to assess patient outcomes linked to metering accuracy and CGM technologies. Ongoing consolidation, partnerships, and regulatory alignment will continue shaping BGMS access and innovation in the coming decade and beyond.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
